Change in Director / Key Managerial Personnel
Nature of change: Cessation of Senior Management Personnel (SMP) due to change in reporting structure.
Individuals and Details:
- Hasmukh Patel: Ceased to be part of Senior Management. Effective date: 30th July 2026 (from close of business hours).
- Sushil Jaiswal: Ceased to be part of Senior Management. Effective date: 30th July 2026 (from close of business hours).
- Sunil Nadkarni: Ceased to be part of Senior Management. Effective date: 30th July 2026 (from close of business hours).
Brief profile and qualifications: Not applicable/disclosed for any of the individuals.
Relationship with other directors: Not applicable/disclosed.
Previous KMP: The three individuals (Hasmukh Patel, Sushil Jaiswal, and Sunil Nadkarni) were the previous holders of the SMP positions. Their tenure ended simultaneously due to the structural change.
Regulatory Compliance:
- The intimation is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The disclosure also references SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026.
- The letter was signed and submitted by Chintan M. Trivedi, Company Secretary, on 30th July 2026.
Key Financial or Operational Approvals
This section is not applicable to the provided data.
Strategic or Business Context
This section is not applicable to the provided data.
Any Other Material Information
- The company's BSE Scrip Code is 500420 and its NSE Scrip Code is TORNTPHARM.
- The formal communication was addressed to the listing departments of both BSE Limited and the National Stock Exchange of India Ltd.